Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 19, No 5 (2023) Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy Abstract  similar documents
A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin
"... of AKI according to the CIN and KDIGO criteria, the frequency of serum creatinine level recovery ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
"... of atorvastatin is demonstrated in according to comparative studies. Results of clinical studies on atorvastatin ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
 
Vol 6, No 5 (2010) THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets
"... Aim. To study the effect of atorvastatin on the rate of atrial fibrillation (AF) recurrence after ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..."
 
Vol 4, No 2 (2008) EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY Abstract  similar documents
A. V. Semenov, D. A. Sichev, V. G. Kukes
"... Aim. To study effects of genes SLCO1B1 and MDR1 polymorphism on atorvastatin pharmacokinetics ..."
 
Vol 10, No 4 (2014) STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN Abstract  similar documents
N. G. Gogolashvili
"... The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... Aim. To assess the safety of the application of high-dose atorvastatin and its effect on metabolic ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..."
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... on the efficacy of atorvastatin therapy and the incidence of the combined endpoint in patients after myocardial ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... antihypertensive and glucose-lowering therapy. Patients of group 1 were additionally receiving atorvastatin 20 mg ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF ..."
 
Vol 1, No 3 (2005) PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE Abstract  similar documents
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova
"... with initial dislipidemia were prescribed lipid reducing drug atorvastatin in 10mg daily dose additionally ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... The results of the recently completed clinical studies on the efficacy of atorvastatin in high ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... of therapy with atorvastatin in different doses in patients with acute ST-segment elevation myocardial ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... high (269, 90.3%) CVR. All patients were recommended to take the reproduced drugs of atorvastatin ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
 
Vol 18, No 3 (2022) Acute Kidney Injury after Transcatheter Aortic Valve Implantation Abstract  similar documents
L. V. Kremneva, L. I. Gapon, S. V. Shalaev, D. V. Krasheninin
"... kidney injury (AKI) was diagnosed according to the KDIGO criteria (2012). The following hospital ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... Aim. To study the effect of atorvastatin on the progression of the arrhythmia in hypertensive ..."
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... дженериков аторвастатина - препарата Тулип в сравнении с дженериком симвастатина Вазилипом у пациентов с ..."
 
Vol 18, No 4 (2022) N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials Abstract  similar documents
E. M. Mezhonov, Yu. A. Vyalkina, S. V. Shalaev
"... . Keywords included MeSH terms «acute kidney injury» or «contrast-induced nephropathy» or «AKI» or «CIN ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
 
Vol 19, No 6 (2023) Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors Abstract  similar documents
L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev
"... to the KDIGO criteria (2012). Results. The number of patients who had pAF after CABG was 29,3%, AKI — 16 ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... up to 8.3%. When choosing among statins specialists recommended significantly more often atorvastatin ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... .32% of patients, enalapril 20 mg/day – 30.45%, simvastatin and atorvastatin 20 mg/day – 64.52% and 47 ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... treatment with atorvastatin for the primary prevention of cardiovascular complications in patients ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... atorvastatin 40 mg per day. Blood LDC levels were examined only in 5% of patients during statins therapy ..."
 
Vol 13, No 6 (2017) SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS Abstract  similar documents
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova
"... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... . Atorvastatin (Tulip, LEK) 20-40 mg OD was prescribed for HH control. Management of CG patients was performed ..."
 
Vol 12, No 2 (2016) CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva
"... , variants of clinical course, and outcomes of acute kidney injury (AKI) in patients with acute ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... with atorvastatin 80 mg/day. The results were considered statistically significant at p<0.05. Results. 16 (27 ..."
 
Vol 14, No 2 (2018) HYPERTENSION AND DIABETES MELLITUS TYPE 2 Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... , hypolipidemic therapy with atorvastatin 17.0Ѓ}4.7 mg/day and combined hypoglycemic therapy with metformin 1093 ..."
 
Vol 16, No 4 (2020) Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice Abstract  similar documents
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan
"... atorvastatin (10-80 mg/day) or rosuvastatin (10-40 mg/day). Group 1 patients had visits to the doctor after 1 ..."
 
Vol 17, No 1 (2021) Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits Abstract  similar documents
S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan
"... atorvastatin (10-80 mg/day) or rosuvastatin (10- 40 mg/day). Group 1 patients had visits to the doctor after 1 ..."
 
Vol 18, No 1 (2022) Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova
"... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..."
 
Vol 7, No 5 (2011) CLINICAL EFFICACY OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETES MELLITUS AND ISCHEMIC HEART DISEASE Abstract  similar documents
L. V. Kozlova, R. A. Khokhlov, N. M. Akhmedzhanov
"... ) and ischemic heart disease (IHD) in prevention of contrast induced nephropathy (CIN). Material and мethods ..."
 
Vol 20, No 4 (2024) Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data Abstract  similar documents
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova
"... KDIGO guidelines. A significant proportion of patients with CHFrEF receive SGLT-2i, but only a third ..."
 
1 - 45 of 45 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)